Equity Details
Price & Market Data
Price: $30.41
Daily Change: -$2.24 / 7.37%
Daily Range: $30.28 - $32.40
Market Cap: $1,763,306,752
Daily Volume: 499,069
Performance Metrics
1 Week: 9.59%
1 Month: 12.13%
3 Months: 5.26%
6 Months: 58.14%
1 Year: 72.78%
YTD: 52.28%
About Oculis Holding AG (OCS)
Get all information on Oculis Holding AG (OCS). Price: 30.41, daily change: -$2.24 / 7.37%. Market cap: 1,763,306,752. Performance for 1-week, 1-month, 52-week.
Company Details
Employees: 60
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: Switzerland
Details
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.